About Christopher Burns
Form D filings for Venatorx Pharmaceuticals from 2013 to 2023 list Christopher Burns as president and director.
Christopher Burns first appears on SEC filings in 2013.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Burns in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher Burns works with at each company, as listed on that company's latest Form D.
Venatorx Pharmaceuticals, Inc. · Form D/A, Jul 13, 2023
TH
Timothy Haines
Director
TH
Tomas Heyman
Director
DP
Daniel Pevear
Executive officer
AM
Anthony Meehan
Executive officer
SP
Sergei Petukhov
Director
MH
Martin Heidecker
Director